DC Chemicals

All products / DC8726

FLLL31
CAT. NO. DC8726

FLLL31

Pack sizes and prices

Pack sizePrice
100 mg$600 USDRequest a quote / confirm availability →
250 mg$1,100 USDRequest a quote / confirm availability →
1 g$2,200 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

FLLL31 selectively binds to Janus kinase 2 and the STAT3 Src homology-2 (SH2) domain, effective inhibitors of STAT3 phosphorylation. STAT3 plays a critical role in early embryogenesis, but is largely dispensable in normal adult cells and tissues. On the other hand the JAK2/STAT3 signaling pathway is persistently activated in great number of human solid and blood cancers. Such activation is commonly associated with a worse prognosis. FLLL31 is a curcumin derivative locked in diketone-tautomeric form, which supposedly improves binding to SH2 domain. The compound inhibits JAK2 kinase activity and prevents STAT3 phosphorylation. FLLK31 is a potent and selective inhibitor of the STAT3 signaling pathway.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC8726
Product nameFLLL31
CAS52328-97-9
Molecular formulaC25H28O6
Molecular weight424.48622
Purity>98%
SMILESCOc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC(C)(C)C)c2C)ccc1O

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — FLLL31 (DC8726)

Related research products

Browse newly added products